The postpartum period presents a critical window to mitigate the long-term risk of metabolic disorders in women with a history of gestational diabetes ...

The postpartum period presents a critical window to mitigate the long-term risk of metabolic disorders in women with a history of gestational diabetes ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of ...

While death rates from cardiovascular disease have declined 60% since 1950, a recent upward trend aligns with increases in ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Losing and regaining weight repeatedly—a pattern known as yo-yo dieting or body-weight cycling—can significantly increase the ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, chief strategy officer, Cluepoints, ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

To avoid a tug-of-war between scientific rigour and operational efficiency, we must focus on the user and data journeys of ...

A preliminary modeling study suggests that four variables accessible at discharge could predict the risk for 90-day ...

Led by Moya Flaherty and Vicky O’Neil, Northampton General Hospitals NHS Trust Background to learning For many staff the COVID-19 pandemic represents the most extraordinary period of their careers. ...